The treatment of Kaposi’s sarcoma: present and future options, a review of the literature7488 Abstract. – Kaposi’s Sarcoma (KS) is an angiogenic tumor involving

Sarcoma de Kaposi: revisión de la literatura e ilustración de un casoACTA MÉDICA GRUPO ÁNGELES. Volumen 11, No. 1, enero-marzo 2013 23 ARTÍCULO

KAPOSI SARCOMA HERPESVIRUS Kaposi sarcoma herpesvirus was considered by a previous IARC Working Group in 1997 (IARC, 1997). Since that time, new data have become available,

Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway Sarah R. Jacobs, Charles

00001t.tifKaposi’s sarcoma-associated Herpesvirus (KSHV) Dimitra Bourboulia for the degree of Doctor of Philosophy Department of Oncology Wolfson Institute for Biomedical

c:/ncn/vir613Journal of General Virology (2002), 83, 1613–1619. Printed in Great Britain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PII: S1535-6108(02)00237-4A R T I C L E Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic

and Sam M Mbulaiteye1 Methods: The study population comprised 2,681 individuals randomly selected from a nationally-representative population-based HIV/AIDS sero-behavioral

Virus-host cell interplay in the pathogenesis of Kaposi’s sarcoma herpesvirussarcoma herpesvirus Fang Cheng Faculty of Medicine University of Helsinki, Finland AcAdeMIc

D H Kedes, D Ganem J Clin Invest. 1997;99(9):2082-2086. https://doi.org/10.1172/JCI119380. Using a cell line (termed BCBL-1) derived from a peripheral effusion (body cavity-based)